T1	Outcomes 604 623	efficacy and safety
T2	Outcomes 1149 1208	Stool cultures for Shigella, Salmonella, Campylobacter spp.
T3	Outcomes 1209 1243	and diarrheagenic Escherichia coli
T4	Outcomes 1293 1321	Clinical response and safety
T5	Outcomes 1442 1451	Shigella;
T6	Outcomes 1461 1472	Salmonella;
T7	Outcomes 1482 1484	E.
T8	Outcomes 1485 1490	coli;
T9	Outcomes 1504 1517	Campylobacter
T10	Outcomes 1519 1552	Overall bacteriologic eradication
T11	Outcomes 1676 1704	Clinical cure or improvement
T12	Outcomes 1792 1818	Serum ciprofloxacin values
T13	Outcomes 1910 1969	MIC50 and MIC90 values for the Shigella and Salmonella spp.
T14	Outcomes 1970 1979	isolated.
T15	Outcomes 1980 2016	Possible drug-related adverse events
T16	Outcomes 2117 2134	Joint examination
T17	Outcomes 2239 2243	safe
T18	Outcomes 2248 2257	effective
